2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
US8492556B2 · kind B2 · utility
9Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2012 |
| Grant date | Jul 23, 2013 |
| Priority date | — |
| Expiry date | Nov 9, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6506
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to novel 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor like-1 (FPRL-1) receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.